Drug-dependent reactions of sera from patients 1 through 5 against different target platelet preparations (flow cytometry)
| Sample . | Normal donor platelets . | GT platelets . | BSS platelets . | EDTA-treated normal platelets . |
|---|---|---|---|---|
| Normal | Neg | Neg | Neg | Neg |
| Patient 1 | Pos | Neg | NT | Neg |
| Patient 2 | Pos | Neg | NT | Neg |
| Patient 3 | Pos | Neg | NT | Neg |
| Patient 4 | Pos | Neg | Pos | NT |
| Patient 5 | Pos | Pos | Neg | NT |
| Sample . | Normal donor platelets . | GT platelets . | BSS platelets . | EDTA-treated normal platelets . |
|---|---|---|---|---|
| Normal | Neg | Neg | Neg | Neg |
| Patient 1 | Pos | Neg | NT | Neg |
| Patient 2 | Pos | Neg | NT | Neg |
| Patient 3 | Pos | Neg | NT | Neg |
| Patient 4 | Pos | Neg | Pos | NT |
| Patient 5 | Pos | Pos | Neg | NT |
GT indicates Glanzmann thrombasthenia (type I); BSS, Bernard-Soulier syndrome; EDTA, ethylenediaminetetraacetic acid; neg, negative; pos, positive; NT, not tested.